Asia Pacific Tyrosine Kinase Inhibitors Market to Gain Momentum...

ha aggiunto una foto Health

2026-11-03 12:33:57 -

Asia Pacific Tyrosine Kinase Inhibitors Market to Gain Momentum with Improving Healthcare Access

The global tyrosine kinase inhibitors (TKIs) market is witnessing significant developments, driven by the increasing prevalence of cancer, rising healthcare expenditure, and growing demand for targeted cancer therapies. The market was valued at more than US$ 18.0 billion in 2017 and was projected to surpass US$ 19.0 billion by 2026. Although the market faced a negative compound annual growth...

0 Commenti 0 condivisioni 7 Views 0 Anteprima